Journal Papers, Abstracts, and Commentaries
|
Journal Papers, Abstracts, and Commentaries
Conference Reports, Abstracts, and Posters
Journal Papers, Abstracts, and Commentaries
|
Conference Reports, Abstracts, and Posters
|
Journal Papers, Abstracts, and Commentaries
|
Journal Papers, Abstracts, and Commentaries
Conference Reports, Abstracts, and Posters
|
Journal Papers, Abstracts, and Commentaries
Journal Papers, Abstracts, and Commentaries
|
Journal Papers, Abstracts, and Commentaries
|
FULL-TEXT
ARTICLE
The acceptability and feasibility of a brief psychosocial intervention to
reduce blood-borne virus risk behaviours among people who inject drugs: a
randomised control feasibility trial of a psychosocial intervention (the
PROTECT study) versus treatment as usual.
Gilchrist G, Swan D, Shaw A, et al
Harm Reduct J. 2017 Mar 21;14(1):14.
Paper
Injecting drug use in prison: prevalence and
implications for needle exchange policy
Wright NM, Tompkins CN, Farragher TM.
Int J
Prison Health. 2015;11(1):17-29.
Abstract
FULL-TEXT
PDF ARTICLE
Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with
National Scale-Up in Coverage of a Combination of Harm Reduction
Interventions.
Palmateer NE, Taylor A, Goldberg DJ, et al
PLoS One. 2014 Aug
11;9(8):e104515
Paper
Association between harm reduction intervention uptake and recent hepatitis C
infection among people who inject drugs attending sites that provide sterile
injecting equipment in Scotland.
Allen EJ, Palmateer NE, Hutchinson SJ,
et al
Int J Drug Policy.
2012 Aug 31
Abstract |
The impact of needle and syringe provision and opiate substitution therapy on
the incidence of Hepatitis C
virus in injecting drug users: pooling of UK evidence.
Turner K, Hutchinson S, Vickerman P,
et al
Addiction. 2011 May 25.
Abstract
Optimal provision of needle and syringe programmes for injecting drug users:
A systematic review.
Jones L, Pickering L, Sumnall H, et al
Int J Drug Policy.
2010 Feb 25.
Abstract |
|
|
|